Blood test for detecting difficult-to-access brain tumors receives breakthrough designation from the US FDA
Blood test for detecting difficult-to-access brain tumours receives breakthrough designation from the US FDA Datar Cancer Genetics created the liquid biopsy to aid in the diagnosis of brain cancers when a traditional biopsy is not an option. A research team at Imperial College, London, conducted a prospective, blinded investigation that demonstrated extremely high accuracy in […]









